RQx Pharmaceuticals
RQx Pharmaceuticals joined the lab to show that the axinellamines, synthesized at scale, are broad-spectrum antibacterial agents.
La Jolla, California
RQx Pharmaceuticals
- Papers together
- 1
- Years
- 2014
- Co-authors
- 1
The record
Our paper with RQx Pharmaceuticals
-
Axinellamines as Broad-Spectrum Antibacterial Agents: Scalable Synthesis and Biology
- RQx Pharmaceuticals Peter A. Smith
No papers match these filters.
Our co-authors at RQx Pharmaceuticals
Peter A. Smith
Keep exploring
More partners
Enamine
HitGen Hongene Biotech Hongene Biotech IKA IKA InduPro Therapeutics InduPro Therapeutics
KULR Technology Socrates Biosciences Socrates Biosciences The Medicines Company The Medicines Company Work with us
Interested in collaborating with the Baran lab?
If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.
Email Philor write to pbaran@scripps.edu